The announcement comes as part of WHO’s broader effort to reduce child mortality, particularly in low- and middle-income ...

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...

New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

The State Government has extended its free RSV immunisation programme for babies and young children, as WA braces for a surge ...

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction ...

Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event ...

Universal immunisation with nirsevimab significantly reduces hospitalizations and paediatric intensive care admissions for ...

Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data show infant respiratory syncytial virus (RSV) ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...